Connect with us

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .

Top Stories

Conflict in Ukraine could aggravate drug problems, EU body warns

2022 06 14T093554Z 1 LYNXMPEI5D0CN RTROPTP 4 UKRAINE CRISIS DRUGS - Global Banking | Finance

By Catarina Demony

LISBON (Reuters) – Russia’s invasion of Ukraine could create “new vulnerabilities” in Europe to illegal drugs by triggering shifts in smuggling routes and potentially exposing more people to narcotics, the Lisbon-based EU drugs agency warned on Tuesday.

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) said in its annual report that many people who have suffered “severe psychological stress” during the conflict may be more vulnerable to substance misuse problems in the future.

Drug traffickers might switch to alternative routes to avoid areas with a heightened security presence, it said, while health services in European countries, especially those bordering Ukraine, are likely to become more strained as drug users fleeing the conflict require support.

“Continuity of treatment, language services and the provision of accommodation and social welfare support are likely to be key requirements,” it said, adding that even those who were not drug users were at risk.

The agency also said the difficult financial situation in Afghanistan that has been under Taliban control since August could make drug revenues a more important source of income and lead to an increase in heroin trafficking to Europe.

It said that despite a ban on the production, sale and trafficking of illicit drugs, poppy cultivation appeared to continue in Afghanistan.

Concerns over the impact international developments could have on drug problems in Europe come at a time substance use is returning to pre-pandemic levels and there are signs of rising production, EMCDDA said. It called on European countries to scale up treatment and harm reduction services.

“Established drugs have never been so accessible, and potent new substances continue to emerge… everyone can be affected, whether directly or indirectly,” said EMCDDA director Alexis Goosdeel.

A record 213 tonnes of cocaine were seized in the European Union and over 350 illegal drug production laboratories dismantled in 2020, according to its latest data.

(Reporting by Catarina Demony; Editing by Andrei Khalip and Toby Chopra)

Global Banking & Finance Review

 

Why waste money on news and opinions when you can access them for free?

Take advantage of our newsletter subscription and stay informed on the go!


By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review │ Banking │ Finance │ Technology. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Post